Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors

OBJECTIVE: Examine the effect of tamoxifen and aromatase inhibitors (AIs) on the risk of 12 clinically relevant cardiovascular outcomes in postmenopausal female breast cancer survivors. METHODS: We carried out two prospective cohort studies among postmenopausal women with breast cancer in UK primary...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Heart
Autores principales: Matthews, Anthony A, Peacock Hinton, Sharon, Stanway, Susannah, Lyon, Alexander Richard, Smeeth, Liam, Lund, Jennifer L, Bhaskaran, Krishnan
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2021
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8327412/
https://ncbi.nlm.nih.gov/pubmed/33177117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-317510
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares